X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (818) 818
Publication (89) 89
Patent (80) 80
Book Review (13) 13
Book Chapter (11) 11
Conference Proceeding (9) 9
Web Resource (6) 6
Magazine Article (5) 5
Book / eBook (3) 3
Newsletter (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (319) 319
animals (222) 222
alzheimer's disease (193) 193
index medicus (117) 117
alzheimers-disease (115) 115
neurosciences (110) 110
biochemistry & molecular biology (107) 107
alzheimer disease - metabolism (104) 104
amyloid beta-peptides - metabolism (102) 102
proteins (95) 95
alzheimers disease (93) 93
brain (89) 89
mice (88) 88
peptides (77) 77
amyloid beta-protein precursor - metabolism (75) 75
research (73) 73
alzheimer disease - pathology (72) 72
human necessities (71) 71
hygiene (70) 70
medical or veterinary science (70) 70
preparations for medical, dental, or toilet purposes (70) 70
amyloid beta-protein (65) 65
brain - metabolism (64) 64
cricetinae (64) 64
amyloid precursor protein (63) 63
biochemistry (63) 63
cho cells (62) 62
mutation (61) 61
neurons (61) 61
alzheimer disease - genetics (60) 60
article (59) 59
multidisciplinary sciences (59) 59
chemistry (57) 57
rats (57) 57
presenilin-1 (56) 56
metallurgy (55) 55
organic chemistry (55) 55
amino acid sequence (54) 54
in-vivo (54) 54
molecular sequence data (54) 54
physics (52) 52
testing (52) 52
cell line (51) 51
investigating or analysing materials by determining theirchemical or physical properties (51) 51
measuring (51) 51
neurology (50) 50
precursor protein (50) 50
membrane proteins - metabolism (48) 48
brain - pathology (47) 47
amyloid beta-protein precursor - genetics (46) 46
peptide (46) 46
amyloid precursor protein secretases (45) 45
cell biology (45) 45
female (45) 45
male (44) 44
physiological aspects (44) 44
aged (43) 43
cells, cultured (43) 43
transgenic mice (43) 43
specific therapeutic activity of chemical compounds ormedicinal preparations (42) 42
transfection (42) 42
a-beta (40) 40
oligomers (40) 40
endopeptidases - metabolism (39) 39
analysis (38) 38
molecular weight (38) 38
neurons - metabolism (38) 38
aspartic acid endopeptidases (36) 36
beer (36) 36
enzymology (36) 36
microbiology (36) 36
mutation or genetic engineering (36) 36
peptide fragments - metabolism (36) 36
spirits (36) 36
vinegar (36) 36
wine (36) 36
clinical neurology (35) 35
culture media (35) 35
cells (34) 34
compositions thereof (34) 34
microorganisms or enzymes (34) 34
pathology (34) 34
propagating, preserving or maintaining microorganisms (34) 34
antibodies (33) 33
fermentation or enzyme-using processes to synthesise a desiredchemical compound or composition or to separate optical isomersfrom a racemic mixture (33) 33
long-term potentiation (33) 33
disease (32) 32
middle aged (32) 32
amyloid beta-peptides - chemistry (31) 31
amyloid beta-peptides - genetics (31) 31
cleavage (31) 31
protein (31) 31
senile plaques (31) 31
alzheimer disease - physiopathology (30) 30
amyloids (30) 30
familial alzheimers-disease (30) 30
membrane proteins - genetics (30) 30
genetic aspects (29) 29
nervous system diseases (29) 29
proteolysis (29) 29
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Science (New York, N.Y.), ISSN 0036-8075, 08/2019, Volume 365, Issue 6453, pp. 540 - 541
Aggregation of the β-amyloid peptide (Aβ) in brain regions serving memory and cognition is thought to initiate Alzheimer's disease (AD) (1). Despite myriad... 
Brain | Signs and symptoms | Neurotoxins | Peptides | Neurodegenerative diseases | β-Amyloid | Toxins | Cognition | Dimers | Glutamatergic transmission | Alzheimers disease | Alzheimer's disease
Journal Article
Cold Spring Harbor Perspectives in Biology, 07/2011, Volume 3, Issue 7, pp. 1 - 16
Journal Article
NATURE REVIEWS NEUROLOGY, ISSN 1759-4758, 07/2019, Volume 15, Issue 7, pp. 365 - 366
In the march towards disease-modifying treatments for Alzheimer disease, immunotherapy with antibodies against amyloid-beta protein is furthest along in human... 
CLINICAL NEUROLOGY | Genetic aspects | Dosage and administration | Drug therapy | Alzheimer's disease | Nervous system agents | Risk factors
Journal Article
Science, ISSN 0036-8075, 09/2017, Volume 357, Issue 6354, pp. 891 - 898
Journal Article
2003, ISBN 3540007075, xiv, 126
Book
Biochemistry, ISSN 0006-2960, 10/2018, Volume 57, Issue 41, pp. 5921 - 5922
Journal Article
Annals of Neurology, ISSN 0364-5134, 2019, Volume 86, Issue 2, pp. 215 - 224
Objective Oligomeric forms of amyloid beta protein (oA beta) are believed to be principally responsible for neurotoxicity in Alzheimer disease (AD), but it is... 
ANTIBODIES | PROTEIN | BIOMARKER | A-BETA | NEUROSCIENCES | BRAIN | CLINICAL NEUROLOGY | Immunoassay | Intravenous administration | Target recognition | Neurodegenerative diseases | Clinical trials | Antibodies | Pharmacology | Cerebrospinal fluid | Oligomers | Neurotoxicity | Biomarkers | Amyloid | Bioindicators | Alzheimer's disease
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 04/2008, Volume 28, Issue 16, pp. 4231 - 4237
Journal Article
Proceedings of the National Academy of Sciences of the United States, ISSN 0027-8424, 09/2016, Volume 113, Issue 36, p. 9958
Journal Article